Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.140
-0.050 (-1.57%)
Oct 29, 2025, 3:36 PM EDT - Market open
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $43.42 million as of October 29, 2025. Its market cap has increased by 28.19% in one year.
Market Cap
43.42M
Enterprise Value
24.11M
1-Year Change
28.19%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since October 24, 2011, Grace Therapeutics's market cap has decreased from $87.20M to $43.42M, a decrease of -50.21%. That is a compound annual growth rate of -4.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 44.11M | 16.32% |
| Dec 31, 2024 | 37.92M | 39.61% |
| Dec 29, 2023 | 27.16M | 21.53% |
| Dec 30, 2022 | 22.35M | -59.95% |
| Dec 31, 2021 | 55.80M | 77.21% |
| Dec 31, 2020 | 31.49M | -84.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |